Profile data is unavailable for this security.
About the company
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
- Revenue in JPY (TTM)509.35bn
- Net income in JPY62.40bn
- Incorporated1947
- Employees4.29k
- LocationOno Pharmaceutical Co Ltd1-8-2, Kyutaro-machi, Chuo-kuOSAKA-SHI 541-8564JapanJPN
- Phone+81 662635670
- Fax+81 662632976
- Websitehttps://www.ono-pharma.com/ja
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sawai Group Holdings Co Ltd | 200.68bn | -1.25bn | 266.31bn | 3.31k | -- | 1.49 | 18.44 | 1.33 | -9.86 | -22.64 | 1,734.07 | 1,548.25 | 0.5445 | 1.28 | 3.40 | 60,628,400.00 | -0.3389 | -0.2327 | -0.4542 | -0.3187 | 28.89 | 32.95 | -0.6224 | -0.475 | 1.08 | -1.04 | 0.4066 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 189.50bn | 29.01bn | 310.56bn | 4.27k | 10.45 | 0.9878 | 7.28 | 1.64 | 387.15 | 387.15 | 2,524.84 | 4,095.99 | 0.374 | 0.7106 | 2.41 | 44,357,680.00 | 6.01 | 5.53 | 8.06 | 6.85 | 47.60 | 49.39 | 16.06 | 14.50 | 1.45 | -- | 0.2856 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
| Nippon Shinyaku Co Ltd | 166.05bn | 29.85bn | 351.26bn | 2.24k | 11.28 | 1.19 | 9.70 | 2.12 | 443.17 | 443.17 | 2,465.26 | 4,211.80 | 0.5421 | 1.17 | 3.19 | 74,028,980.00 | 9.75 | 10.89 | 10.81 | 12.74 | 67.29 | 63.93 | 17.98 | 17.67 | 4.04 | -- | 0.0089 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Hisamitsu Pharmaceutical Co Inc | 159.27bn | 19.99bn | 465.27bn | 2.80k | 22.35 | 1.61 | 16.90 | 2.92 | 276.99 | 276.99 | 2,208.13 | 3,837.32 | 0.4704 | 2.64 | 3.42 | 56,901,390.00 | 6.04 | 4.34 | 7.25 | 4.99 | 59.05 | 57.83 | 12.84 | 10.32 | 3.28 | -- | 0.0086 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
| Santen Pharmaceutical Co Ltd | 287.99bn | 30.60bn | 551.89bn | 3.85k | 18.61 | 1.94 | 11.33 | 1.92 | 92.03 | 92.03 | 865.27 | 880.97 | 0.7205 | 2.26 | 4.18 | 74,823,070.00 | 7.63 | 3.94 | 9.43 | 4.93 | 56.89 | 58.97 | 10.59 | 6.01 | 1.89 | -- | 0.1757 | 71.86 | -0.6494 | 4.43 | 36.09 | 8.94 | 3.61 | 5.92 |
| Rohto Pharmaceutical Co Ltd | 335.80bn | 34.48bn | 580.76bn | 9.14k | 16.58 | 1.93 | 11.16 | 1.73 | 148.28 | 148.28 | 1,444.67 | 1,272.14 | 0.7768 | 2.32 | 4.55 | 36,723,640.00 | 8.02 | 8.59 | 11.20 | 11.70 | 56.06 | 57.78 | 10.33 | 10.57 | 1.43 | -- | 0.1452 | 21.12 | 13.95 | 10.38 | 0.2263 | 15.01 | 10.42 | 22.59 |
| Sumitomo Pharma Co Ltd | 453.40bn | 110.09bn | 1.18tn | 3.83k | 10.72 | 4.08 | 8.97 | 2.61 | 277.11 | 277.11 | 1,141.22 | 727.28 | 0.5438 | 1.95 | 3.99 | 118,318,100.00 | 13.20 | -5.49 | 23.02 | -8.49 | 59.24 | 67.88 | 24.28 | -13.24 | 1.01 | 4.17 | 0.4726 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Ono Pharmaceutical Co Ltd | 509.35bn | 62.40bn | 1.27tn | 4.29k | 19.17 | 1.42 | 12.77 | 2.49 | 132.76 | 132.76 | 1,084.01 | 1,786.88 | 0.4702 | 2.14 | 3.38 | 118,811,500.00 | 5.77 | 10.78 | 6.61 | 12.37 | 69.79 | 73.23 | 12.27 | 21.23 | 2.56 | 125.26 | 0.1283 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
| Kyowa Kirin Co Ltd | 496.83bn | 67.04bn | 1.36tn | 5.67k | 20.24 | 1.52 | 14.62 | 2.74 | 128.07 | 128.07 | 949.13 | 1,706.50 | 0.4568 | 1.82 | 2.99 | -- | 6.16 | 6.40 | 7.33 | 7.37 | 74.25 | 74.99 | 13.49 | 14.37 | 2.35 | -- | -- | 46.19 | 0.2559 | 9.31 | 11.98 | 7.35 | 19.80 | 7.10 |
| Eisai Co Ltd | 808.19bn | 42.76bn | 1.46tn | 13.51k | 32.95 | 1.58 | 17.41 | 1.80 | 151.67 | 151.67 | 2,866.61 | 3,153.46 | 0.5537 | 0.7996 | 3.33 | 59,839,040.00 | 3.04 | 3.81 | 4.22 | 5.14 | 77.75 | 77.47 | 5.48 | 6.44 | 1.54 | -- | 0.2015 | 98.01 | 6.42 | 2.56 | 9.49 | -17.54 | -14.48 | 0.00 |
| Shionogi & Co Ltd | 465.35bn | 194.86bn | 3.07tn | 4.96k | 15.07 | 1.94 | 14.22 | 6.60 | 228.94 | 228.94 | 546.70 | 1,779.33 | 0.2869 | 0.8648 | 2.76 | 93,915,640.00 | 11.98 | 12.17 | 13.13 | 13.74 | 84.50 | 84.91 | 41.78 | 38.30 | 5.21 | -- | 0.0148 | 27.87 | 0.7325 | 5.62 | 5.19 | 6.88 | 34.66 | 12.30 |
| Astellas Pharma Inc | 2.06tn | 322.91bn | 4.40tn | 13.64k | 13.54 | 2.47 | 8.55 | 2.14 | 179.57 | 179.57 | 1,145.43 | 984.21 | 0.5841 | 1.27 | 2.90 | 151,038,200.00 | 9.15 | 3.05 | 14.11 | 4.45 | 81.00 | 81.15 | 15.67 | 5.42 | 0.839 | 41.32 | 0.2913 | 131.42 | 19.25 | 8.01 | 197.72 | -23.64 | -5.94 | 13.09 |
| Daiichi Sankyo Co Ltd | 2.05tn | 304.60bn | 5.60tn | 19.77k | 18.06 | 3.20 | 14.78 | 2.73 | 163.62 | 163.62 | 1,103.05 | 924.09 | 0.5649 | 0.8183 | 3.11 | 103,827,400.00 | 8.38 | 5.72 | 10.55 | 7.11 | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | 49.57 | 17.77 | 13.95 | 44.47 | 17.77 | 29.01 | 20.79 |
Data as of Feb 17 2026. Currency figures normalised to Ono Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
18.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 17.10m | 3.43% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 14.54m | 2.92% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 12.33m | 2.47% |
| BlackRock Fund Advisorsas of 30 Jan 2026 | 12.27m | 2.46% |
| BlackRock Japan Co. Ltd.as of 30 Jan 2026 | 8.62m | 1.73% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 7.07m | 1.42% |
| Charles Schwab Investment Management, Inc.as of 05 Feb 2026 | 6.76m | 1.36% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 6.56m | 1.32% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 5.17m | 1.04% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 4.07m | 0.82% |
More ▼
Data from 31 Dec 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
